The vaccine recognizes and destroys tumor cells in the immune system of mice, preventing up to 88% of cases of advanced cancer.

A team from the University of Massachusetts in Amsterdam joined the team in stopping melanoma, pancreatic cancer, and breast cancer. Two immunosuppressive agents were prepared in single lipid nanoparticles. A stimulant that utilizes the innate and adaptive immune response. The first is carried out quickly and non-specifically, the second provides targeted and long-term protection due to T‑ and B‑cells. They also form a coordinated defense against the missile.

In the experiment, nanoparticles produced lymphocytes and activated dendritic cells. The combination of 100% pure peptides rejected the tumor, then like all mice without air treatment for a month. Surviving the first shock of tumor-free cells many months later is a sign of a long-lasting immune system. .

The developers are developing their products both as treatment methods and as preventive measures against non-standard types of stands. The technology development uses a NanoVax starter. Therapy.

Source: Tech Cult

Previous articleRestrictions on bank cards in Russia come into force in December.
Next articleIvanovo scientist producing harmful substances
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.

LEAVE A REPLY

Please enter your comment!
Please enter your name here